Integragen Net Income Over Time
| ALINT Stock | EUR 0.18 0.01 5.88% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Integragen Performance and Integragen Correlation. Integragen |
Cross Equities Net Income Analysis
Compare Integragen and related stocks such as Transgene SA, Genfit SA, and Adocia Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNG | (11.9 M) | (43.6 M) | (43.2 M) | (42.9 M) | (48.6 M) | (46.4 M) | (25.2 M) | (32.3 M) | 8 M | (18.8 M) | (18.4 M) | (20 M) | (32.8 M) | (22.3 M) | (34 M) | (30.6 M) | (32.1 M) |
| GNFT | 2.6 M | (9.7 M) | (5.4 M) | (12.7 M) | (17 M) | (17.1 M) | (33.7 M) | (58.6 M) | (79.5 M) | (65.1 M) | (101.2 M) | 67.3 M | (23.7 M) | (28.9 M) | 1.5 M | 1.4 M | 1.4 M |
| ADOC | (4.7 M) | (6.5 M) | (6 M) | (4.3 M) | (20.7 M) | 12.6 M | (7.9 M) | (8.6 M) | 7.6 M | (18.6 M) | (23.3 M) | (22.8 M) | (6.9 M) | (21.2 M) | (9.3 M) | (8.4 M) | (8.8 M) |
| IPH | (6.1 M) | (7 M) | (3.2 M) | (2.9 M) | (19.6 M) | (6.7 M) | 12.6 M | (48.4 M) | 3 M | (20.8 M) | (64 M) | (52.8 M) | (58.1 M) | (7.6 M) | (49.5 M) | (44.5 M) | (42.3 M) |
| GBT | 17.2 M | 14.4 M | 20.4 M | 20.5 M | 26.1 M | 39.9 M | 28.9 M | 46.2 M | 46.8 M | 37.3 M | 18.2 M | 32.6 M | (41.1 M) | 23.9 M | 16.1 M | 14.5 M | 17.7 M |
| ABNX | (7.7 M) | (7.7 M) | (7.7 M) | (7.7 M) | (6.6 M) | (16.6 M) | (24.9 M) | (5 M) | (6.3 M) | 1.8 M | (1.9 M) | (5.8 M) | (4.2 M) | (3.5 M) | (4.4 M) | (5.1 M) | (5.3 M) |
| ALSEN | (487.2 K) | (487.2 K) | (987.3 K) | (1.6 M) | (3.1 M) | (4.3 M) | (7.4 M) | (9.7 M) | (12.4 M) | (12.1 M) | (9 M) | (15.1 M) | (23.2 M) | (22.1 M) | (26 M) | (23.4 M) | (22.2 M) |
| OSE | (1.4 M) | (1.4 M) | (1.4 M) | (250 K) | (2.8 M) | (5.6 M) | 20.7 M | (10.5 M) | 5.5 M | (4.7 M) | (16.6 M) | (16.9 M) | (17.8 M) | (23 M) | 37.4 M | 33.7 M | 35.4 M |
| LNA | 1.9 M | 8.3 M | 6.2 M | 7.7 M | 7 M | 10.6 M | 21.6 M | 24.2 M | 21.5 M | 20.8 M | 7.8 M | 23.5 M | 25.8 M | 23.4 M | 21.8 M | 25.1 M | 13.6 M |
| MAAT | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (4.5 M) | (6.6 M) | (5.3 M) | (9 M) | (13.7 M) | (19.7 M) | (28.9 M) | (26 M) | (24.7 M) |
Integragen and related stocks such as Transgene SA, Genfit SA, and Adocia Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Integragen financial statement analysis. It represents the amount of money remaining after all of Integragen operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Integragen | ALINT |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Genopole Campus 1 |
| Exchange | Euronext Paris |
EUR 0.18
Additional Tools for Integragen Stock Analysis
When running Integragen's price analysis, check to measure Integragen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integragen is operating at the current time. Most of Integragen's value examination focuses on studying past and present price action to predict the probability of Integragen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integragen's price. Additionally, you may evaluate how the addition of Integragen to your portfolios can decrease your overall portfolio volatility.